U.S. Office REITs Stock News

NasdaqGS:AAPL
NasdaqGS:AAPLTech

Wearable Technology Innovators Stock Picks One Pure Play One Giant One Underdog

Artificial intelligence is starting to reshape how people interact with devices, and wearable technology sits right in the middle of that shift. From smart glasses and camera earbuds to AI agents that might one day replace many app taps, this change could matter for investors watching the next wave of consumer hardware. Qualcomm is one of the companies pushing new AI-powered designs, and that activity can ripple across suppliers, component makers, and device platforms. This article breaks...
NasdaqGS:ROKU
NasdaqGS:ROKUEntertainment

Tesla Stock And Two Founder-Led Giants With Unpriced Upside

Founder-led companies can offer something many investors value in a world of shifting rates, cooler inflation reads, and fast-moving sentiment: leaders with skin in the game who are deeply tied to the long term outcome. While central banks reassess policy paths and bond yields adjust to softer energy prices, some investors look for businesses where the founder’s reputation and wealth are closely linked to the company’s future. This article highlights 3 of the stocks from our Founder-Led...
NasdaqGS:PCAR
NasdaqGS:PCARMachinery

Is PACCAR’s Rising Parts And Financial Services Mix Altering The Investment Case For PCAR?

PACCAR recently reported first-quarter 2026 results showing higher net income supported by resilient parts and financial services operations, even as truck deliveries softened and production discipline kept capacity in check. With an expanding production backlog and a greater share of earnings coming from parts and financial services, PACCAR is increasingly insulated from the swings of the cyclical truck market. We’ll now examine how the stronger parts and financial services contribution...
NasdaqGS:AFYA
NasdaqGS:AFYAConsumer Services

Afya (AFYA) Stock Could Be 19.2% Undervalued On Its Medical Education Growth Narrative

Afya (NasdaqGS:AFYA) is back in focus after recent trading put its month and past 3 months performance under scrutiny, prompting investors to reassess what the current $13.95 share price implies. See our latest analysis for Afya. Recent trading has been soft, with the 7 day share price return down 3.39% and the year to date share price return down 6.69%. The 3 year total shareholder return of 11.37% contrasts with a 5 year total shareholder return decline of 45.10%, which points to mixed...
NasdaqGM:STAA
NasdaqGM:STAAMedical Equipment

STAAR Surgical (STAA) Stock Could Be 4.4% Undervalued Despite Its Rich P S Multiple

Why STAAR Surgical Stock Is Drawing Attention Now STAAR Surgical (STAA) is back on investors’ radar after a volatile period, with the stock up over the past 3 months but down over the past month and past year. See our latest analysis for STAAR Surgical. Recent trading paints a mixed picture for STAAR Surgical, with the share price at $28.37 after a 90 day share price return of 58.94%, but a 5 year total shareholder return that declined 80.85%. This suggests near term momentum in contrast with...
NYSE:KLAR
NYSE:KLARDiversified Financial

Klarna Ulta Beauty Deal Tests Growth Hopes Against Valuation Concerns

Klarna Group (NYSE:KLAR) has partnered with Ulta Beauty to provide flexible payment options for U.S. online shoppers. The partnership gives Ulta.com and Ulta Beauty app users access to Klarna's installment and pay-later services. This agreement expands Klarna's presence in U.S. beauty and retail e-commerce. Klarna Group, trading at $17.6, is adding Ulta Beauty to its merchant network, giving the payment provider another large U.S. retail partner in the beauty category. The stock is up 6.3%...
NasdaqGM:AIOT
NasdaqGM:AIOTElectronic

PowerFleet (AIOT) Stock Faces Ongoing Losses As EPS Improvement Tests Bullish Narratives

PowerFleet (AIOT) has just wrapped up FY 2026 with Q4 revenue of US$114.5 million and a reported loss of US$2.7 million, or EPS of US$0.02, while the trailing 12 month figures show revenue of US$443.8 million and a loss of US$20.6 million, or EPS of US$0.15. Over recent quarters, the company has seen revenue move from US$103.6 million in Q4 FY 2025 to US$114.5 million in Q4 FY 2026, with quarterly EPS shifting from a loss of US$0.09 to a loss of US$0.02. At the same time, trailing 12 month...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

Lantheus (LNTH) Stock And The Valuation Implications Of Its Award-Winning Imaging Agent

Lantheus Holdings (LNTH) recently drew attention after its investigational PET/CT agent LNTH-2513 (18F-GP1) received SNMMI’s Image of the Year award, backed by trial data on diagnosing acute lower-extremity deep vein thrombosis. See our latest analysis for Lantheus Holdings. The recent SNMMI recognition and upcoming Goldman Sachs healthcare conference appearance come as the stock trades at US$104.67, with a 30-day share price return of 11.46% and a year to date share price return of 55.60%,...
NYSE:DOCN
NYSE:DOCNIT

DigitalOcean (DOCN) Stock After New AI-Focused Hires And AI-Native Cloud Launch Is Valuation Stretched Or Justified

DigitalOcean Holdings (DOCN) is back in focus after the company appointed three senior executives with deep roots in cloud and AI infrastructure, shortly after rolling out its AI-Native Cloud platform. See our latest analysis for DigitalOcean Holdings. The share price has moved sharply in recent months, with a 30-day share price return of 17.06% and a 90-day share price return of 133.65%. The 1-year total shareholder return is also very large, suggesting momentum has strengthened around the...
NasdaqGS:QLYS
NasdaqGS:QLYSSoftware

Qualys (QLYS) Stock Valuation Check After Recent Rebound And DCF Discount

Qualys (QLYS) has drawn investor attention after recent price moves, with the stock up about 27% over the past month and about 21% over the past 3 months from its recent levels. See our latest analysis for Qualys. Despite the recent momentum, with a 30 day share price return of 27.36% and a 90 day share price return of 20.58%, Qualys still has a year to date share price return decline of 12.49% and a 1 year total shareholder return decline of 17.66%. Recent gains are rebuilding after a weaker...
NYSE:ECG
NYSE:ECGConstruction

Does ECG's Sector Selloff Sensitivity Hint At A Deeper Question About Its Risk Profile?

In recent trading, Everus Construction Group was caught in a past broad selloff across the engineering and construction sector, with investors rotating away from the space as peers also weakened. The steeper reaction in Everus shares compared with sector peers hints at investor sensitivity to sector-wide swings, even without fresh company-specific developments. We’ll now examine how this sector-wide pressure on engineering and construction stocks could influence Everus Construction Group’s...
NYSE:TGT
NYSE:TGTConsumer Retailing

Target Taps Isaac Mizrahi To Shape Design Identity And Investor Story

Target (NYSE:TGT) has appointed designer Isaac Mizrahi as its first creative director at large. Mizrahi will mentor Target's in house design team, guide product development, and support new brand partnerships. The role also includes launching a mentorship program aimed at developing emerging creative talent within the company. For investors watching NYSE:TGT, this move comes with the stock trading at $133.17, after returns of 7.4% over the past week and 9.6% over the past month. The shares...
NasdaqGS:CECO
NasdaqGS:CECOMachinery

CECO Environmental (CECO) Stock Price Surge Sparks Fresh Valuation Questions

Investors may be wondering if CECO Environmental at around US$95 per share still offers value, or if most of the opportunity is already priced in. The stock recently closed at US$95.01, with returns of 18.0% over 7 days, 17.5% over 30 days, 58.9% year to date and 224.3% over the past year, while the 3‑year and 5‑year returns are very large. Recent attention on CECO Environmental has centred on its share price strength and how the market is reassessing the company within the broader machinery...
NasdaqGM:AVBP
NasdaqGM:AVBPBiotechs

ArriVent BioPharma (AVBP) Stock Valuation After Growing Expectations For EGFR Firmonertinib Trials

EGFR Market Attention Puts Focus on ArriVent BioPharma Recent commentary on the EGFR inhibitor market, highlighting precision medicine trends and ArriVent BioPharma (AVBP) firmonertinib trials in non small cell lung cancer, has pushed this clinical stage stock back onto investor watchlists. See our latest analysis for ArriVent BioPharma. At a latest share price of US$30.30, ArriVent's short term share price return has been relatively steady. The 30 day share price return of 8.7% and year to...
NYSE:MGM
NYSE:MGMHospitality

MGM Take Private Bid And Insider Exit Refocus Ownership And Risk

People Inc. has submitted a major cash proposal to acquire NYSE:MGM and take the company private. The MGM board is formally reviewing the offer, signaling an active M&A process. Major insider He Chaolian has fully exited MGM, marking a complete sale of that insider stake. The proposal and insider exit together point to a significant shift in MGM's ownership structure and governance. MGM Resorts International, traded as NYSE:MGM, operates casinos, resorts and entertainment properties,...
NYSE:RL
NYSE:RLLuxury

Ralph Lauren (RL) Stock After Q1 Beat And Softer Oil Prices Is The Valuation Premium Still Justified

Ralph Lauren (RL) has been back in focus after first quarter 2026 results beat Wall Street expectations. In addition, falling oil prices improved the consumer spending backdrop, lifting the stock to a fresh 52 week high. See our latest analysis for Ralph Lauren. The recent first quarter earnings beat and easing energy costs have coincided with strong momentum, with a 30 day share price return of 26.18% and a 1 year total shareholder return of 54.33%. If this kind of consumer strength has your...
NYSE:THO
NYSE:THOAuto

Thor Industries (THO) Stock Valuation Weighs Undervalued P/E Against Bearish Cash Flow Signals

Recent Performance Snapshot THOR Industries (THO) has seen mixed share performance, with the stock down over the past year and year to date, but showing a gain over the past month and a decline over the past 3 months. At a recent close of US$75.98 and a market value of about US$4.0b, the company reports annual revenue of US$9.82b and net income of US$262.46m. See our latest analysis for THOR Industries. Recent trading shows momentum fading, with the share price down 27.93% year to date and...
NYSE:ELV
NYSE:ELVHealthcare

Low Volatility Health Stocks Hiding Unseen Cash Flow Power

High interest rates, rising oil prices and concerns around an AI-fueled bubble are making many investors rethink how much risk they really want in their portfolios. Instead of chasing the hottest stories, some are looking at larger companies that historically show calmer price swings and stronger balance sheets. This article focuses on three stocks from a low volatility screener that appear particularly exposed to these macro trends and could either help cushion the bumps or feel the strain...
NasdaqCM:ATEX
NasdaqCM:ATEXTelecom

Anterix (ATEX) Is Up 28.6% After Turning Profitable And Completing $23M Buyback Program

In June 2026, Anterix reported fourth-quarter sales of US$1.96 million and full-year sales of US$6.50 million, with net income rising to US$18.52 million for the quarter and US$90.64 million for the year, alongside the completion of a share repurchase program totaling 691,534 shares for US$23.26 million. Beyond the headline figures, Anterix’s shift to profitability, new utility contracts for its Private LTE and spectrum solutions, and a cash balance above US$98 million with no debt...
NasdaqCM:CELC
NasdaqCM:CELCBiotechs

Should Celcuity’s $500 Million Convertible Notes and VIKTORIA-1 Data Shift the CELC Investment Thesis Require Action From Celcuity (CELC) Investors?

Earlier this month, Celcuity Inc. priced an upsized US$500,000,000 offering of 0.250% convertible senior notes due 2032 and outlined plans to use the proceeds to repay existing debt and fund working capital, clinical development, potential commercialization and possible future acquisitions. In parallel, Celcuity reported detailed Phase 3 VIKTORIA-1 data showing gedatolisib-based regimens improved progression-free outcomes versus alpelisib plus fulvestrant in PIK3CA mutant advanced breast...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Baidu (NasdaqGS:BIDU) Stock Valuation After Apollo Go’s New Switzerland Permit

Why Baidu (NasdaqGS:BIDU) is back in focus after Switzerland’s Apollo Go permit Baidu (NasdaqGS:BIDU) is in the spotlight after Switzerland’s Federal Roads Office granted a special permit for Level 4 autonomous operations. This allows its Apollo Go powered AmiGo service to run trials in Eastern Switzerland. This permit supports Baidu’s push to apply its autonomous driving system in real world European conditions, with open road testing already underway across an approximately 80 km service...
NYSE:AWK
NYSE:AWKWater Utilities

Inflation Test For US Utilities One Growth Engine One Quiet Cash Flow

With inflation readings running hot, producer costs climbing, and interest rates holding steady, many investors are rethinking how to position around essential services and pricing power. Utilities can sit at an interesting crossroads when energy prices and input costs move, and not all stocks react in the same way to these pressures. This article focuses on three US utilities stocks from our screener that appear especially exposed to the current inflation and rate backdrop. You will see how...
NasdaqCM:BULL
NasdaqCM:BULLCapital Markets

Webull Rolls Out AI MCP Server As Retail Trading Habits Evolve

Webull has rolled out a Model Context Protocol (MCP) server that lets retail investors use natural language to access trading tools and place orders. The launch is aimed at bringing AI powered, context aware trading capabilities to a broader set of Webull users, not just developers and quant focused traders. MCP is designed to connect everyday investors to real time data and execution through simple text based prompts inside the Webull platform. For investors watching Webull, ticker...
NYSE:AHR
NYSE:AHRHealth Care REITs

Did American Healthcare REIT’s US$705.6 Million Equity Raise and Forward Sale Just Shift AHR’s Story?

American Healthcare REIT Inc. recently priced an underwritten public offering of 14,000,000 common shares, tied to a forward sale agreement with the underwriter, which is expected to raise approximately US$705.6 million in gross proceeds before expenses for general corporate purposes and potential future investments. This large equity raise and use of a forward sale structure highlights management’s focus on securing flexible funding for future healthcare real estate opportunities while...